Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

Volume: 365, Issue: 1, Pages: 32 - 43
Published: Jul 7, 2011
Abstract
Nesiritide is approved in the United States for early relief of dyspnea in patients with acute heart failure. Previous meta-analyses have raised questions regarding renal toxicity and the mortality associated with this agent.We randomly assigned 7141 patients who were hospitalized with acute heart failure to receive either nesiritide or placebo for 24 to 168 hours in addition to standard care. Coprimary end points were the change in dyspnea at 6...
Paper Details
Title
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
Published Date
Jul 7, 2011
Volume
365
Issue
1
Pages
32 - 43
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.